2 Articles
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
A Tool to Make FDA Drug Approval Practices Transparent
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process